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ABSTRACT
Suppression of the effects of an spt10 mutation on
ADH2 expression is a phenotype shared by a small
number of genes whose protein products are either
components of the CCR4-NOT complex required for
mRNA deadenylation and degradation (CCR4, CAF1,
NOT4) or have been shown to interact with the complex (DBF2, SRB9, SRB10). In this work, we conducted a screen for additional suppressors of spt10 at
ADH2 to identify new factors related to CCR4 function. In addition to reisolating ccr4 and caf1 alleles,
three previously unidentified suppressors of spt10
were obtained: ebs1, lsm6, and nup159. These three
genes are known or presumed to affect mRNA export
or degradation. Mutations in EBS1, LSM6 and NUP159 not only suppressed spt10-induced ADH2 expression but also, like ccr4 and caf1 defects, reduced the
ability of ADH2 to derepress. None of these defects
affected the expression of CCR4-NOT complex components or the formation of the CCR4-NOT complex.
The reduced ADH2 expression was also not the result
of increased degradation of ADH2 mRNA, as the lsm6
and nup159 alleles, like that of a ccr4 deletion, actually
slowed ADH2 degradation. Our results indicate that
alterations in factors that slow mRNA degradation or
affect mRNA transport may also interfere with the
synthesis of mRNA and suggest an integration of such
events in gene expression.
Keywords: CCR4-NOT Complex; Transcription;
mRNA Degradation; mRNA Export

1. INTRODUCTION
The CCR4 protein is involved in several processes controlling the metabolism of mRNA in the cell: mRNA
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initiation, elongation, and degradation. CCR4 was originally identified as a mutation that suppressed the increased ADH2 expression on glucose caused by a spt10
allele, cre1-1 [1]. SPT10 is known to function in part by
controlling histone gene expression, which in turn can
alter chromatin structure and gene expression at sensitive
loci [2]. The interaction of CCR4 with SPT10 is not limited to the ADH2 promoter, as ccr4 also suppressed
spt10 at the his4-912 locus [3]. CCR4 is also required
for maximal expression of ADH2 and other nonfermentative genes [1] and appears involved in other processes
such as cell wall integrity, amino acid metabolism, cell
cycle progression, and DNA repair [4-8]. The effects of
CCR4 at ADH2 and presumably many of these other
processes occur at the transcriptional level implicating
CCR4 in the control of mRNA initiation.
CCR4 functions in the context of two CCR4-NOT
complexes, 1.0 and 1.9 MDa in size. The 1.0 MDa complex contains CCR4, CAF1, the five NOT proteins (NOT1NOT5) and three other proteins, CAF40, CAF130 and
BTT1 [6,9,10]. In addition to CCR4, mutations in both
CAF1 and NOT4 suppress the effects of an spt10 mutation at ADH2 and affect the derepression of ADH2, suggesting that they also are involved in the activation of
transcription [6,11].
The NOT1-5 proteins, however, are clearly involved
in the repression of transcription [12,13], initially identified by their binding and restricting TFIID access to noncanonical TATAA sequences [14]. In addition, the CCR4NOT proteins have been suggested to play a role in
mRNA elongation [15]. Recent studies indicate that the
CCR4-NOT complex is responsible for restarting transcription after transcriptional arrest has occurred [16].
One defined biochemical function for CCR4 is that it
is the catalytic component of the cytoplasmic deadenylase complex [18-20]. CCR4 mRNA poly (A) deadenylation is the first step in targeting the mRNA for degradation and caf1 or not4 defects also lead to defects in
deadenylation [19,20]. A ccr4 defect, therefore, in stabi-
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lizing mRNA would augment mRNA levels. This effect
would be opposite in nature to the ccr4 suppression of
spt10 effects at ADH2 or the requirement of CCR4 for
ADH2 and other genes’ syntheses. The CCR4 effect on
ADH2 RNA accumulation implies that it operates by
mechanisms other than or in addition to controlling
mRNA degradation.
To gain further insight into the mechanisms of how
CCR4 activates gene expression, we have reconducted
the screen for factors that can suppress spt10-enhanced
expression at ADH2. The only known suppressors of
spt10 effects are defects in the CCR4, CAF1 and NOT4
proteins, all components of the CCR4-NOT complex,
and the DBF2, SRB9 and SRB10 proteins, which are
known to associate with the CCR4-NOT complexes [5,
21]. The SRB9 and SRB10 proteins have been shown to
be part of mediator, the transcriptional activator complex
[21,22]. Hence, the ability to suppress spt10-enchanced
ADH2 expression reflects a common factor related to
CCR4 function, and possibly to a role not directly involving effects on mRNA degradation. Utilizing this
screen for suppressors of spt10, we have identified three
new genes which when mutated are capable of suppressing spt10: NUP159, LSM6 and EBS1. These three factors,
like CCR4, CAF1 and NOT4 are known or presumed to
be involved in controlling mRNA export or degradation.
These results suggest that defects in factors involved in
post-transcriptional regulation of mRNA metabolism may
result in corresponding decreases in transcriptional initiation. The CCR4 requirement at ADH2 may, therefore,
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result from indirect effects involving the integration of
mRNA synthesis with the subsequent nuclear export and
degradation of mRNA.

2. MATERIALS AND METHODS
2.1. Yeast Strains and Growth Medium
Yeast strains are listed in Table 1. Strains were grown on
YEP medium (1% yeast extract/2% Bacto-peptone) supplemented with 2% glucose and 2% agar (YD plates).
Allyl alcohol was added to YD plates in the concentration
indicated in the test. ADH assays were conducted as
previously described [6].

2.2. Analysis of spt10 Suppressors
Standard genetic techniques were used to identify complementation groups. Yeast transformations were conducted with either an YCp50-LEU2, YEpl3, or YEp24
based genomic library. Western analysis was conducted
as described [6] using antibody specific to CCR4-NOT
protein components [23].

2.3. RNA Analysis
S1 nuclease protection assays were conducted to quantitate ADH2 mRNA levels as described [17,24]. The rates
of ADH2 mRNA half-lives were determined following
growth of yeast on YEP medium containing 2% glycerol/
2% ethanol and shifting to YEP medium containing 8%
glucose as previously indicated [17].

Table 1. Yeast strains.
Strain

Genotype

553-4b

MATa adh1-11 adh3 cre1-1 ural leu2 trp1

553-4b-10

MATa adh1-11 adh3 cre1-1 ccr4-10 ural leu2 trp1

43-2B

MAT adh1-11 adh3 ural his4

43-2B-M1

MAT adh1-11 adh2-1 adh3 ural his4

1076-2c

MAT ura3 his3 leu2 trp1 ccr4::URA3

1005-2-3c

MATa adh1-11 his3 ura3 trp1 leu2 caf1::LEU2 spt10::trp1

1005-2-3c-s

MAT adh1-11 his3 ura3 trp1 leu2 caf1::LEU2 spt10::trp1

BA1-1

MAT adh1-11 leu2 asg1-4-6

BA2-1

MAT adh1-11 leu2 his4 ebs1-1-42

BA3-1

MAT adh1-11 leu2 lsm6-5-17

BA4-1

MAT adh1-11 leu2 trp1 asg4-4-33

BA5-1

MAT adh1-11 leu2 trp1 asg5-5-37

BA6-1

MAT adh1-11 trp1 nup159-6-72

994-2

MAT adh1-11 his3 ura3 leu2 spt10::TRP1

994-2-EBS1

MAT adh1-11 his3 ura3 leu2 spt10::TRP1 ebs1::URA3

LGY101

MAT rat7-1 his3200 ura3-52 leu21

AEMY19

MAT trp11 his3200 ura3-1 leu2-3,-112 lsm6::URA3

Copyright © 2012 SciRes.
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3. RESULTS
3.1. A Screen for Suppressors of spt10 at ADH2
In order to identify other factors that are functionally
related to the CCR4-NOT proteins, we conducted a
search for additional suppressors of the spt10 effects at
the ADH2 locus using a strain carrying the defective
adh1-1 allele. The increased expression of ADH2 caused
by spt10 results in an inability of strains to grow in the
presence of ally1 alcohol. Ally1 alcohol can be converted
by ADH enzymes to acrolein that kills the cells. While
ccr4 alleles were previously identified by such a screen
[1], in order to identify new suppressors we used a modified selection process. In the previous screen, mutations
that allowed growth on ally1 alcohol-containing plates
were then tested for sensitivity to the respiratory inhibitor Antimycin A; complete loss of both ADH I and ADH
II enzyme activity in the cell would require the utilizetion of oxidative phosphorylation rendering such cells
Antimycin A sensitive. This secondary requirement resulted in the elimination of nearly 90% of the ally1 alcohol revertants [1]. Since there is a narrow range of
ADH enzyme activities that allows growth on both ally1
alcohol and resistance to antimycin A we were intent on
identifying new suppressors of spt10 that resulted in
ADH II activity that fell into this range.
Strain 553-4b, containing a spt10 mutant allele called
cre1-1, was chosen for this screen since the cre1-1 allele,
unlike an spt10 deletion, does not result in phenotypes
typically associated with ccr4 or not defects: these phenotypes include temperature sensitivity, slow growth,
and sensitivity to caffeine. Approximately 1 × 108 cells
of strain 553-4b were spread onto YD plates containing
10 mM ally1 alcohol. 198 ally1 alcohol resistant colonies
were selected for analysis. Complementation analysis,
following mating each of these revertants to strain 432B-M1 carrying a defective adh2 allele, identified 99 of
these revertants as containing mutations in the ADH2
gene (data not shown).
Since ccr4 and defects in other CCR4-NOT complex
components are sensitive to caffeine and a number of
other factors such as high temperature and elevated salt
concentration, the remaining 99 revertants were tested
for sensitivity to these conditions. Sixteen of the 99
showed sensitivity to one or more of the following conditions: 8 mM caffeine, 37˚C, 16˚C, 0.75 M MgCl2, or
0.2 M LiC1 (Table 2; data not shown) and were chosen
for further analysis.

3.2. Identification of Known Suppressors of
spt10
To test if any of these 16 revertants generated in this
screen were ccr4 mutations, Western analysis was conCopyright © 2012 SciRes.

ducted on each strain to determine if the CCR4 protein
was absent. Extracts from only one revertant, 553-4b-165, lacked detectable CCR4 protein (data not shown; see
also Figure 1). In addition, genetic complementation
analysis was conducted by crossing a ccr4-containing
strain to all the revertants. In this case, only revertant
553-4b-1-65 failed to complement a ccr4 allele. Similarly, a caf1 strain, 1005-2-3c-s, was crossed to all revertants to identify those that contained caf1 mutations. ReTable 2. Phenotypic characterization of spt10 revertants.
Strain

Allele

553-4b-10

8 mM Caff

YD 37˚

0.2 M LiCl

ccr4-10

–

w/+

–

1-65

ccr4-1-65

–

w/–

–

4-26

caf1-4-26

–

–

–

1-42

ebs1-1-42/asg2

+

–

–

5-17

lsm6-5-17/asg3

–

–

+

6-72

nup159-6-72/asg6

–

+

+

4-6

asg1-4-6

–

+

+

1-36

asg1-1-36

–

+

+

1-52

asg1-1-52

–

+

+

1-53

asg1-1-53

–

+

+

1-58

asg1-1-58

–

+

+

4-11

asg1-4-11

–

+

+

5-15

asg1-5-15

–

+

+

5-21

asg1-5-21

–

+

+

5-84

asg1-5-84

–

+

+

6-16

asg1-6-16

–

+

+

4-33

asg1-4-33

–

+

+

Yeast strains were grown on YEP medium containing 2% glucose supplemented with 8 mM caffeine (8 mM caff) or 0.2 M LiC1. Growth was at
30˚C except as indicated. “+”: very good growth; “w/+”: good growth;
“w/–”: poor growth; “–”: no growth.

Figure 1. nup159, lsm6 and ebs1 alleles do
not affect the expression of CCR4-NOT components. Western analysis was conducted on
yeast extracts with antibodies directed against
CCR4, CAF1, NOT4, and CAF40. Left lane(wt) strain 553-4b; other lanes-strain 553-4b
except containing the allele as indicated.
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vertants 553-4b-4-26 and -6-72 partially failed to complement the caf1 mutation, although not completely, so
that we were unable to conclusively identify these revertants as containing caf1 mutations. To clarify this result,
the mutation in revertant 553-4b-4-26 was cloned by
complementation using a genomic library and the complementing gene was shown to contain the complete
CAF1 gene following DNA sequence analysis. Subsequent retransformation of the CAF1 containing genomic
clone into revertant 553-4b-6-72 failed to complement its
defects, demonstrating that 553-4b-4-26 is the only caf1
mutation produced by this screen. Crosses with strains
containing either a dbf2 or not4 mutation showed that
none of the remaining revertants carried mutations in
either of these genes.
Additional complementation analysis grouped the remaining 14 revertants that displayed pleiotropic effects
into four complementation groups (Table 2). Most of the
complementation groups were represented by a single
revertant, whereas complementation group designated
asg1 contained 10 members.
ADH II enzyme activity assays were conducted on the
16 revertants from each of these complementation groups,
the parent strain 553-4b, and 553-4b-10, which contains
the previously characterized ccr4-10 allele (Table 3).
The ADH II assay values that were obtained confirm that
growth on ally1 alcohol was due to reduced expression
of ADH2. As expected, values for many of the revertants
were not as low as the ccr4-containing strain 553-4b-10
since many of the revertants identified were not Antimycin A sensitive (data not shown). On glucose, most reverTable 3. ADH2 expression in spt10 revertants.
Allele

ADH II enzyme activity

ADH2 mRNA

Glc

EtOH

Glc

EtOH

wt

52

2400

1.0

1.0

ccr4-10

16

620

0.32

ND

ccr4-1-65

22

730

ND

ND

caf1-4-26

19

250

0.12

0.39

ebs1-1-42

27

1700

0.59

0.64

lsm6-5-17

15

1400

0.50

0.38

nup159-6-72

26

240

0.41

0.49

asg1-4-6

24

570

0.41

ND

asg1-4-33

43

940

ND

ND

ADH II enzyme activities were conducted as described previously following
growth in YEP medium supplemented with 8% glucose (Glc) or 3% ethanol
(EtOH) [46]. The standard error of the mean (SEM) for all ADH assays was
less than 20% and the values represent the average of at least four determinations. ADH2 mRNA levels were quantitated using an S1 nuclease protection assay as described in Figure 2 using ACT1 mRNA levels as a standard.
The ADH2 mRNA levels were normalized against levels found in the parent
strain 553-4b which is given a value of 1.0. The SEMs for the ADH2 mRNA
levels were less than 20% except for lsm6 and caf1 under ethanol growth
conditions in which the values were 37% and 28%, respectively.

Copyright © 2012 SciRes.
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tants displayed at least a two-fold reduction of ADH II
activity compared to the parental strain (Table 3). Assay
values for these revertants grown in ethanol medium
showed a wide range of values. Most of the activity
levels in these revertants fell into an intermediate range
around 1000 mU/mg of ADH II. For the ten alleles of
asg1 the range of ADH II activities under ethanol conditions was from 440 to 1200 mU/mg. These results indicate that the spt10 revertants, like previously identified
ccr4 and caf1 alleles, suppressed both spt10-induced
ADH2 expression and the ability of ADH2 to derepress
under non-fermentative growth conditions.

3.3. Cloning of ASG2, 3, and 6
In order to clone the respective genes for the remaining
unidentified complementation groups, a representative
from each group was transformed with either or both low
and high copy yeast genome libraries. Depending on the
phenotype of the representative mutant, selection for
complementing plasmids was conducted on different media. Repeated attempts to complement asg1 failed, however, and complementing clones were only obtained for
asg2, asg3 and asg6.
For strain 553-4b-6-72 (asg6), complementing plasmids were selected on 8 mM caffeine plates. A single
plasmid (6-72-1), derived from a YCp50-LEU2 genomic
library, was identified and was shown to contain an 8.4
Kbp fragment of Chromosome IX. Three genes were
identified on this plasmid that could potentially be
responsible for complementing 553-4b-6-72: YIL113w,
POR2 and NUP159. Given the function of NUP159 as
involved in mRNA transport out of the nucleus and that a
defect in such a gene could result in lowered gene
expression, a nup159 strain (LGY101) was obtained carrying the rat7-1 mutation (RAT7 is the same as NUP159).
Crossing strain LGY101 to strain 553-4b-6-72, resulted
in diploids that failed to grow on 8 mM caffeine plates,
indicating that the asg6-6-72 mutation could not complement the rat7-1 mutation. asg6-6-72 was therefore designated as an allele of NUP159. The NUP159 protein has
recently been shown to play an important role in mRNA
transport by aiding DBP5 remodeling of the mRNP
complex [25], but otherwise has no direct role in mRNA
expression.
Revertant 553-4b-5-17 (asg3) when transformed with
the yeast genomic library YEp13 yielded one transformant that was caffeine resistant and that was also unable
to grow on 10 mM ally1 alcohol media. The insert contained in plasmid 5-17-1 was determined to be a 6.5 Kbp
fragment of chromosome IV containing three genes,
ATP17, LSM6 and RGA2. RGA2 has been described as a
GTPase activating protein, LSM6 is involved in RNA
splicing processing and mRNA decapping [26,27] and
OPEN ACCESS
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ATP17 is a subunit of ATP synthase. A BamHI-SalI
fragment of plasmid 5-17-1 that contained ATP17 and
LSM6 was subcloned into pRS315, a single copy plasmid
containing a LEU2 gene. This plasmid was able to complement the caffeine sensitive phenotype of 5-17, showing that one of these two genes, but not RGA2, was responsible for this complementation. Also, following transformation of a YCp50-LEU2, single copy yeast genomic
library, into 553-4b-5-17, a single caffeine resistant colony was obtained that contained a plasmid with both
ATP17 and LSM6 genes (data not shown). An lsm6containing strain, AEMY19, was crossed to 5-17, and the
resulting diploid strain failed to grow in the presence of 8
mM caffeine. This failure to complement indicates that
the asg3-5-17 mutation is an allele of lsm6.
Strain 553-4b-1-42 (asg2) after transformation with a
YEp13 high copy yeast genomic library yielded a single
plasmid that could complement the ability to grow at
37˚C and the allyl alcohol phenotype. The insert was
found to be a 4.3 Kbp region of chromosome IV containing a single gene, EBS1. EBS1 was initially reported
to be involved in telomere maintenance based on its sequence similarity to EST1 [28] but more recently it has
been shown to be the ortholog of the higher eukaryotic
nonsense-mediated decay protein SMG7 [29]. Its involvement in nonsense mediated decay may be only one
means that its is involved in mRNA expression, as it has
also been demonstrated that EBS1 binds eIF4E, the
mRNA cap binding protein required for translational
initiation. In fact, EBS1 is a negative regulator of translation [30]. EBS1 also binds DCP1 [31], a component of
the mRNA decapping complex [20]. Its exact role in
decapping is not understood, as it does not clearly affect
mRNA degradation rates (R. Parker, pers. comm), and
more recent studies indicate that it does not affect MFA2
decapping [29]. Removal of amino acids 456-783 from
EBS1, that overlap a putative RNA recognition motif,
resulted in an EBS1-expressing plasmid that was unable
to complement the 37˚C growth defect of the 553-4b-1-42,
demonstrating that the EBS1 gene complemented 5534b-1-42 and that this deleted region is required for EBS1
function. We also showed that deleting ebs1 gave the
same phenotype as the ebs1-1-42 allele in that it was
capable of suppressing an spt10 deletion in its effects on
either ADH2 or HIS4 (data not shown).

3.4. spt10 Suppressors Affect ADH2 Expression
at the Transcriptional Level
The identification of three additional suppressors of
spt10 as factors involved in mRNA degradation (LSM6
and EBS1), translation (EBS1), and transport (NUP159)
coincide with the role of the other spt10 suppressors,
CCR4, CAF1 and NOT4, that have known roles in posttranscriptional control of mRNA metabolism, including
Copyright © 2012 SciRes.

that of mRNA degradation, translation, and elongation
[17-20,32]. We subsequently investigated whether the
effects of these new spt10 suppressors were the result of
reducing ADH2 mRNA expression. ADH2 mRNA levels
were quantitated by S1 analysis and are summarized in
Table 3 (see also Figure 2, where the zero time points
are representative assays conducted under ethanol growth
conditions). Each of the lsm6-17, ebs1-1-42, nup159-6-72
and asg1-4-6 alleles reduced spt10-enhanced ADH2
mRNA expression by around two-fold or more under
glucose growth conditions and by a similar level following ethanol growth conditions. It should be mentioned
that the spt10 allele does not affect ADH II enzyme levels following ethanol growth conditions [1,3]. Therefore, the effects of these suppressor mutations on ADH II
activity following non-fermentative growth represent
direct effects on ADH2 expression. These results indicate
that these alleles reduce ADH II enzymatic levels by primarily reducing the steady state levels of ADH2 mRNA
levels. Therefore, as previously found for CCR4 and
CAF1 [3,11] (Table 3), these new spt10 suppressors are
required for activating ADH2 expression. It should be
noted, however, that under ethanol growth conditions the
actual steady state reduction in ADH2 mRNA levels by
lsm6 and nup159 did not appear to directly correlate with
the degree of reduction in the levels of ADH II enzyme
activity (Table 3). The cause for this is unclear but could
result from the unknown nature of the mutation or possibly even from pleiotropic effects on the translatability
or expression of the mRNA.

3.5. lsm6, ebs1, and nup159 Alleles Do Not Affect
Expression of CCR4-NOT Complex
Components
One likely cause for the suppression of spt10 and of
ADH2 gene expression by the lsm6, ebs1 and nup159
alleles is that they reduce the levels of key CCR4-NOT
complex components. The levels of CCR4-NOT complex
proteins were subsequently determined by Western analysis in strains carrying these mutant alleles. As shown in
Figure 1, lsm6, ebs1 and nup159 had no effect on the
relative abundance of CCR4, CAF1, and other complex
components. We also found that the integrity of the
CCR4-NOT complex, as evidenced by co-immunoprecipitation, to be unaffected by the lsm6, ebs1, and nup159
alleles (data not shown). These data indicate that lsm6,
ebs1, and nu159 affect ADH2 expression by a means
other than through indirect effects on the CCR4-NOT
complex.

3.6. lsm6, ebs1, nup159 Decrease or Have No
Effect on ADH2 mRNA Half-Lives
Both LSM6 and EBS1 have known or suggested roles in
OPEN ACCESS
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lsm6-5-17 and nup159-6-72 slowed ADH2 mRNA degradation (Figure 2 and summarized in Table 4) while the
ebs1-1-42 allele had no effect on ADH2 mRNA stability.
These results indicate that lsm6, nup159, ccr4 [17,33]
and caf1 (data not shown) all increase the stability of
ADH2 mRNA. Their effects on reducing the steady state
levels of ADH2 mRNA must hence even be greater than
the effects that are summarized in Table 3. Clearly, the
reduction in ADH2 mRNA levels caused by these alleles
is not occurring through direct effects on enhancing
ADH2 mRNA degradation. These results, in contrast,
suggest that interfering with post-transcriptional processes
can reduce the level of mRNA synthesis.

4. DISCUSSION

Figure 2. nup159, lsm6 and ebs1 alleles increase or have no effect on ADH2 mRNA stability. S1 nuclease protection assays were performed on 40 g of total RNA using an oligonucleotide specific to the 5’ region of ADH2
and to ACT1 [17]. ADH2 mRNA stability was
determined as previously described [17] following shifting of yeast from ethanol-containing medium to glucose-containing medium at
time zero. The ebs1, nup159 and lsm6 alleles
are the same as described in Table 2.

controlling the rate of mRNA degradation, with lsm6
slowing mRNA decapping and EBS1 interacting with the
decapping complex or controlling at least nonsense mediated decay [26,27,29]. It was theoretically possible,
however, that the lsm6 and ebs1 alleles identified in this
spt10 screen were mutations that enhanced the rate of
ADH2 mRNA degradation, thereby suppressing spt10
effects on the initiation of ADH2 synthesis and reducing
ADH2 expression under non-fermentative growth conditions. To test this hypothesis we examined the rate of
ADH2 mRNA degradation in each of these mutated
strains. ADH2 mRNA half-lives were determined following pre-growth of yeast under ethanol (non-fermentative conditions) and shifting them to glucose growth
conditions upon which ADH2 syntheses is rapidly shut
off. Although in an spt10 background there is a low level
of ADH2 expression under glucose growth conditions,
this level is much less than found under non-fermentative
conditions (Table 3 and Figure 2) allowing mRNA halflives to be readily calculated.
The ADH2 mRNA half-life was found to be about 12
min in agreement with previous results [17,33]. Both
Copyright © 2012 SciRes.

CCR4 has been considered an activator of transcription
since it first was identified as a suppressor of spt10
effects at ADH2 and as being required for ADH2 derepression following non-fermentative growth [1,3]. The
mechanism by which it and other factors related to it,
such as CAF1 or NOT4, are required for maintaining
ADH2 mRNA levels has remained, however, obscure [5,
6,11,21]. The identification of the CCR4-NOT complex
as involved in mRNA deadenylation, with CCR4 and
CAF1 as deadenylases [17-20,32,34], indicate that ccr4
and caf1 deletions actually stabilize ADH2 mRNA and
hence raise its mRNA levels, not lower them [17,33]. In
this report we identify three new factors, NUP159, LSM6
and EBS1, whose defects, like those of caf1 and ccr4,
suppress spt10-enhanced ADH2 expression and decrease
the ability of ADH2 to derepress. The known or putative
roles of NUP159, LSM6, and EBS1 in the post-transcriptional regulation of mRNA suggests, therefore, a functional link to CCR4 and CAF1 and a common mechanism
by which they all affect ADH2 expression.
The lsm6-5-17, nup159-6-72 and ebs1-1-42 alleles
effect on ADH2 mRNA levels were not the result of
increasing the rate of ADH2 mRNA degradation. In fact,
lsm6 and nup159 stabilized ADH2 mRNA, indicating
that their effects on the synthesis of the mRNA was at
least two-fold greater than that observed from monitoring
ADH2 steady state mRNA levels. Similar conclusions
Table 4. Effect of spt10 revertants on ADH2 mRNA half-life.
Allele

ADH2 mRNA half-life (min)

wt

12 ± 0.40

ebs1-1-42

13 ± 0.90

lsm6-5-17

29 ± 9.1

nup159-6-72

26 ± 0.16

ADH2 mRNA half-lives were calculated as described [17]. ADH2 mRNA
levels were quantitated by S1 nuclease protection assays. The value ± SEMs
represent the average of three to five determinations except for lsm6 whose
value is the average of two determinations.
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can be made for ccr4 and caf1 defects that caused increased stabilization of ADH2 mRNA and yet, concurrently, reduced overall ADH2 mRNA levels [3,17,33]
(Table 3). We also showed that the lsm6, nup159 and
ebs1 alleles did not alter the abundance of CCR4-NOT
complex components, indicating that their effects were
not indirectly through lowering CCR4 and CAF1 abundance in the cell. In addition, the role of EBS1 in negatively regulating translation [30] cannot directly explain
how it would function as an activator of ADH2.
spt10 results in a low level of ADH2 expression under
glucose growth conditions by an unknown mechanism
that could involve affecting ADH2 chromatin structure [2,
35,36]. The observation that lsm6, nup159, ebs1, ccr4
and caf1 can each suppress spt10 effects at ADH2 could
suggest that these factors function downstream of spt10
on chromatin structure. However, our previous analyses
indicated that CCR4 acted independently of SPT10 to
affect ADH2 expression [36]. Also, the fact that lsm6,
nup159, ebs1, caf1 and ccr4 reduce ADH2 expression
under ethanol growth conditions when spt10 has no
effect on ADH2 transcription further supports an effect
of these alleles on ADH2 independently of spt10.
One possible model for how CCR4 and CAF1 function
in activation is that they influence action of the RNA
polymerase II holoenzyme through their contacts to
SRB-9, -10, and -11 mediator components [21]. Alternatively, CCR4 and CAF1 could serve as coactivators by
somehow mediating the action of activators such as
ADR1 at ADH2. However, this latter model seems unlikely in that ADR1 is not required for spt10-enhanced
ADH2 expression [1,11].
Based on the results presented in this paper, we
suggest a different model for how CCR4, CAF1, LSM6,
NUP159 and EBS1 act as activators at the ADH2 locus.
The primary roles for these factors appear to be the
mRNA degradative process, in mRNA transport from the
nucleus, or in mRNA elongation. Studies have increasingly linked transcription initiation processes with posttranscriptional processing and transport of mRNA [37].
It is, therefore, conceivable that interfering with mRNA
degradation and transport could result in slower processing and movement of mRNA through the cell. These
effects could then result indirectly in reducing transcriptional initiation of particularly sensitive genes. A variant
of this model would be that proteins involved in posttranscriptional mRNA processing are loaded onto the
mRNA during its synthesis. Defects in these processing
components would interfere with this loading process
that again indirectly influences the corresponding initiation of transcription from certain promoters. In this regard
CCR4-NOT complex is known to play a critical role in
mRNA elongation [15,16,38]. Its function as an activator
of transcriptional elongation would therefore be a very
Copyright © 2012 SciRes.

direct way for components of this complex to function as
activators of ADH2 expression. For example, if transcription through the ADH2 gene were particularly prone to
transcriptional arrests that the CCR4-NOT complex would
be especially able to bypass by restimulating transcription
[16], then a positive role for CCR4-NOT proteins would
be substantiated. But no evidence for ADH2 susceptibility
to transcriptional arrest is known and the EBS1, NUP159
and LSM6 factors do not have clear roles in elongation.
Finally, it has been recently shown that the nuclear
pore factors may have diverse and direct effects on chromatin structure and hence gene expression [39]. Given
these interactions between mRNA transport and transcription, the NUP159 protein and the CCR4-NOT complex, which has been shown to interact with the mRNA
export pathway [40], may exert their respective effects
on ADH2 chromatin structure and expression by virtue of
their effects on mRNA export. Since the SPT10 protein
is specifically involved in affecting chromatin structure
[2,35,36], this could be one means by which defects in
NUP159 and CCR4-NOT components suppress spt10
effects.
In contrast to the above models, given that CCR4,
CAF1, LSM6, NUP159 and EBS1 defects might be
expected to have broad affects on the mRNA degradation
and/or transport of many genes [39-41], it remains possible that the mRNA for certain key transcriptional initiation factors might be specifically sensitive to corresponding defects in mRNA degradation or transport. For instance, the mRNA for holoenzyme or core initiation components might be specifically affected by such defects,
resulting again, indirectly, in reduced ADH2 gene expression. However, whole genome microarray analysis
with ccr4, caf1 and not4 deletions did not identify
specific core transcriptional factors under the regulation
of any of the CCR4-NOT factors [10].
In that ccr4, caf1, lsm6 and nup159 defects all reduce
ADH2 steady state mRNA levels and at the same time
reduce the rate of ADH2 mRNA degradation indicates an
additional difficulty with interpreting the actual mechanisms by which factors control gene initiation. A number
of factors thought to control initiation of transcription
(HPR1, RTF1, PAF1, SPT5) have been shown to be involved in post-initiation processes [33,38,42-45]. Whether
these original effects on transcription initiation were
merely the consequences of indirect effects derived from
their post-initiation sites of action has not been determined. At least for the case of CCR4-NOT factors
understanding how their effects on ADH2 mRNA degradation rates can exert opposite effects on ADH2 synthesis
may shed new light on the total integration of mRNA
metabolism.
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